(Q45972793)

English

Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

1 reference

based on heuristic

inferred from title

author name string

M Awwad

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

R J North

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

publication date

1 September 1988

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

65

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

87-92

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes: a possible mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

?-Irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Models of adoptive T-cell-mediated regression of established tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ly-1+2- suppressor T cells inhibit the expression of passively transferred antitumor immunity by suppressing the generation of cytolytic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of the antitumor immune response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive chemoimmunotherapy of murine leukemia with helper T lymphocyte clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular Immunity Against Tumor Antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passive Immunotherapy of Cancer in Animals and Man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of experimental contact sensitivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The genetic and cellular basis of regulation of the immune response to tumor antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Cyclophosphamide on Immunological Control Mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allospecific suppression without requirement for participation of Ly 2+ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2972604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/2972604

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45972793&oldid=1381278569"